These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24935984)

  • 1. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.
    Kuhle J; Gaiottino J; Leppert D; Petzold A; Bestwick JP; Malaspina A; Lu CH; Dobson R; Disanto G; Norgren N; Nissim A; Kappos L; Hurlbert J; Yong VW; Giovannoni G; Casha S
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):273-9. PubMed ID: 24935984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein Are Related to the Neurological Impairment and Spinal Edema after Traumatic Spinal Cord Injury.
    Leister I; Altendorfer B; Maier D; Mach O; Wutte C; Grillhösl A; Arevalo-Martin A; Garcia-Ovejero D; Aigner L; Grassner L
    J Neurotrauma; 2021 Dec; 38(24):3431-3439. PubMed ID: 34541888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Against the odds: what to expect in rehabilitation of chronic spinal cord injury with a neurologically controlled Hybrid Assistive Limb exoskeleton. A subgroup analysis of 55 patients according to age and lesion level.
    Grasmücke D; Zieriacks A; Jansen O; Fisahn C; Sczesny-Kaiser M; Wessling M; Meindl RC; Schildhauer TA; Aach M
    Neurosurg Focus; 2017 May; 42(5):E15. PubMed ID: 28463613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
    Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
    PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury.
    Ueno T; Ohori Y; Ito J; Hoshikawa S; Yamamoto S; Nakamura K; Tanaka S; Akai M; Tobimatsu Y; Ogata T
    Spinal Cord; 2011 Mar; 49(3):333-6. PubMed ID: 20805831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
    Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study.
    Hayakawa K; Okazaki R; Ishii K; Ueno T; Izawa N; Tanaka Y; Toyooka S; Matsuoka N; Morioka K; Ohori Y; Nakamura K; Akai M; Tobimatsu Y; Hamabe Y; Ogata T
    Spinal Cord; 2012 Jul; 50(7):493-6. PubMed ID: 22270191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
    Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
    Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
    Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
    Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NfL and pNfH are increased in Friedreich's ataxia.
    Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
    J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
    Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
    Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of magnetic resonance diffusion tensor imaging parameters with American Spinal Injury Association score for prognostication and long-term outcomes.
    Shabani S; Kaushal M; Budde M; Kurpad SN
    Neurosurg Focus; 2019 Mar; 46(3):E2. PubMed ID: 30835673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.
    Singer W; Schmeichel AM; Sletten DM; Gehrking TL; Gehrking JA; Trejo-Lopez J; Suarez MD; Anderson JK; Bass PH; Lesnick TG; Low PA
    Clin Auton Res; 2023 Dec; 33(6):635-645. PubMed ID: 37603107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectory of Serum Levels of Glial Fibrillary Acidic Protein Within Four Weeks Post-Injury Is Related to Neurological Recovery During the Transition from Acute to Chronic Spinal Cord Injury.
    Leister I; Altendorfer B; Maier D; Mach O; Wutte C; Grillhösl A; Arevalo-Martin A; Garcia-Ovejero D; Aigner L; Grassner L
    J Neurotrauma; 2023 May; 40(9-10):999-1006. PubMed ID: 36200629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury.
    Stukas S; Cooper J; Gill J; Fallah N; Skinnider MA; Belanger L; Ritchie L; Tsang A; Dong K; Streijger F; Street J; Paquette S; Ailon T; Dea N; Charest-Morin R; Fisher CG; Bailey CS; Dhall S; Mac-Thiong JM; Wilson JR; Christie S; Dvorak MF; Wellington CL; Kwon BK
    Neurology; 2023 Mar; 100(12):e1221-e1233. PubMed ID: 36599698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
    Wurster CD; Steinacker P; Günther R; Koch JC; Lingor P; Uzelac Z; Witzel S; Wollinsky K; Winter B; Osmanovic A; Schreiber-Katz O; Al Shweiki R; Ludolph AC; Petri S; Hermann A; Otto M;
    J Neurol; 2020 Jan; 267(1):36-44. PubMed ID: 31552549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament light as a biomarker in traumatic brain injury.
    Shahim P; Politis A; van der Merwe A; Moore B; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Gill JM; Brody DL; Zetterberg H; Blennow K; Chan L
    Neurology; 2020 Aug; 95(6):e610-e622. PubMed ID: 32641538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.